TrialJournal of the American Heart Association2025

Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial.

Niekbachsh Mohammadnia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.